Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05648773 · ClinicalTrials.gov registry record · NA
COVID-19 Booster Incentives
A NA study of Booster Message and Booster Message + Financial Incentive, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 57,893
- Enrollment target
- 1
- Study location
NCT05648773 is a NA study of Booster Message and Booster Message + Financial Incentive that has completed, run by University of Southern California. The registered enrollment target is 57,893 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05648773, a NA study of Booster Message and Booster Message + Financial Incentive, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 57,893 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).
Conditions Studied
Interventions
- OTHER Placebo
- BEHAVIORAL Financial Incentive
- BEHAVIORAL Messaging
Study Locations (1)
California
- Contra Costa Health Plan - Martinez
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57,893 participants |
| Start Date | 2022-12-08 |
| Est. Completion | 2022-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05648773
The ClinicalTrials.gov registry entry for NCT05648773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57,893 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Booster Message appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05648773 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05648773 about?
NCT05648773 is a clinical study titled "COVID-19 Booster Incentives". The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our e...
What is the current status of trial NCT05648773?
This trial is currently completed. It is a NA study. The enrollment target is 57,893 participants. The study started on 2022-12-08. Estimated completion is 2022-12-23.
What conditions does trial NCT05648773 study?
This clinical trial studies the following conditions: Booster Message, Booster Message + Financial Incentive.
What interventions are being tested in trial NCT05648773?
The interventions under investigation include: Placebo (OTHER), Financial Incentive (BEHAVIORAL), Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT05648773?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05648773 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.